Diabetes Clinical Trials in San Francisco

Showing 121-140 of 405 trials

Kaiser Permanente Evaluation of Medically Tailored Meals in Adults With Medical Conditions at High Readmission Risk

NCT05166525

This study is a virtual, remote, decentralized pragmatic clinical trial comparing the efficacy of medically tailored meals alone or medically tailored meals with remote nutritional counseling compared with usual standard of care in adults with a targeted, nutrition-sensitive chronic medical condition (heart failure, diabetes mellitus, chronic kidney disease).

Heart FailureChronic Kidney DiseasesDiabetes Mellitus, Type 2

Kaiser Permanente2,000 participantsStarted Apr 2020

Oakland, California, United States • San Francisco, California, United States • San Rafael, California, United States +2 more locations

COMPLETEDPhase 1< 1 mile

T1DM Immunotherapy Using Polyclonal Tregs + IL-2

NCT02772679

The purpose of this study is to assess the safety of Tregs + IL-2 and survival of Tregs in patients with recent onset T1DM who receive infusions of autologous Tregs + IL-2.

Type 1 Diabetes Mellitus

Jeffrey Bluestone16 participantsStarted Aug 2016

San Francisco, California, United States • New Haven, Connecticut, United States

COMPLETEDPhase 38.4 miles

Mylan Insulin Aspart Study

NCT03760068

The aim of this phase III trial is to demonstrate the equivalence in the safety and efficacy profile between MYL-1601D and NovoLog® in patients with T1DM.

Diabetes Mellitus, Type 1

Mylan Inc.478 participantsStarted Nov 2018

Montgomery, Alabama, United States • Phoenix, Arizona, United States • Phoenix, Arizona, United States +155 more locations

Kaiser Permanente Evaluation of Medically Tailored Meals in Adults With Medical Conditions at High Readmission Risk

T1DM Immunotherapy Using Polyclonal Tregs + IL-2

Mylan Insulin Aspart Study

Diabetes Trials in Other Cities

Comparison of SAR341402 to NovoLog/NovoRapid in Adult Patients With Diabetes Mellitus Also Using Insulin Glargine

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes Mellitus on Basal Plus Mealtime Insulin

Non-inferiority Study to Compare the Efficacy and Safety of Mylan's Insulin Glargine With Lantus® in Type 2 Diabetes Mellitus Patients (INSTRIDE 2)

Non-inferiority Study to Compare the Efficacy and Safety of Mylan's Insulin Glargine With Lantus® in Type 1 Diabetes Mellitus Patients (INSTRIDE 1)

Effect of Efpeglenatide on Cardiovascular Outcomes

SUSTAIN SWITCH: A Research Study to Compare Two Dose Schedules of Semaglutide Taken Once Weekly in People With Type 2 Diabetes

A Study of Dulaglutide (LY2189265) in Children and Adolescents With Type 2 Diabetes

Adverse Metabolic Effects of Dietary Sugar

Safety Evaluation of the Hybrid Closed Loop (HCL) System in Pediatric Subjects With Type 1 Diabetes

The HOMBRE Trial: Comparing Two Innovative Approaches to Reduce Chronic Disease Risk Among Latino Men

Onduo Virtual Diabetes Clinic Study

Performance of the Dexcom Continuous Glucose Monitoring (CGM) System in Pregnant Women With Diabetes Mellitus

A Study of Tirzepatide (LY3298176) Versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Participants With Type 2 Diabetes

A Study of HTD1801 in Adults With Nonalcoholic Steatohepatitis (NASH) and Type 2 Diabetes Mellitus (T2DM)

User Performance of the CONTOUR NEXT and CONTOUR TV3 Blood Glucose Monitoring System (BGMS)

Comparison of the Safety and Efficacy of HOE901-U300 With Lantus in Children and Adolescents With Type 1 Diabetes Mellitus

Alveolar Bone Changes in Diabetes (ABCD) Study

Other Conditions in San Francisco